Phenotropil (Fonturacetam) [Phenylpiracetam] 30 tablets 100 mg

Instructions for Phenotropil (Fonturacetam) [Phenylpiracetam] 30 tablets 100 mg

Composition Phenotropil

One tablet contains:
active ingredient:
Fonturacetam - 50.00 mg or 100.00 mg;
auxiliary substances:
povidone K-17, microcrystalline cellulose, sodium carboxymethyl starch, magnesium stearate.

Pharmacological effect

Pharmacotherapeutic group: nootropic agent

Pharmacological effect Phenotropil

Pharmacotherapeutic group: the nootropic agent PHENOTROPYL, a nootropic drug, has a pronounced antiamnestic effect, has a direct active and energetic effect on the integrative activity of the brain, promotes memory consolidation, improves attention concentration and mental activity, facilitates learning, increases the rate of information transfer between cerebral hemispheres, increases the resistance of brain tissue to hypoxia and toxic effects, has anticonvulsant and anxiolytic activity, regulates the processes of activation and inhibition of the CNS, and improves mood.

PHENOTROPIL has a positive effect on the metabolic processes and blood circulation of the brain, stimulates oxidation-reduction processes, increases the energy potential of the body through the utilization of glucose, improves regional blood flow in ischemic areas of the brain. It increases norepinephrine, dopamine and serotonin levels in the brain, does not affect GABA levels, does not bind to GABA or GABAB receptors, does not have a noticeable effect on spontaneous brain bioelectric activity.
PHENOTROPIL has no effect on breathing and the cardiovascular system, has an insignificant diuretic effect, has anorexigenic activity in course of administration.
The stimulating effect of PHENOTROPYL is manifested in its ability to have a moderate effect on motor reactions, to increase physical efficiency, to a pronounced antagonism to the cataleptic effect of antipsychotics, and also in the weakening of the hypnotic effect of ethanol and hexenal.
The psychostimulatory effects of PHENOTROPYL prevail in the ideal sphere.
The drug has a moderate psychostimulatory effect with anxiolytic activity, improves mood, and has some analgesic effect, raising the threshold for pain sensitivity.
Adaptogenic effects of PHENOTROPYL are manifested in increased resistance to stress in the conditions of extreme mental and physical exertion, fatigue, hypokinesia and immobilization, at low temperatures.
With PHENOTROPYL, improvement of vision is observed, which manifests itself in an increase in sharpness, brightness and fields of vision.
PHENOTROPIL improves blood supply to the lower extremities.
PHENOTROPIL stimulates antibody production in response to antigen administration, indicating immunostimulating properties, but it does not promote immediate-type hypersensitivity or alter the allergic skin inflammatory response to foreign protein.
Therapeutic PHENOTROPIL does not induce drug dependence, tolerance, or withdrawal syndrome.
PHENOTROPIL is effective at a single dose, which is important when using the drug in extreme conditions.
PHENOTROPIL is not teratogenic, mutagenic, carcinogenic or embryotoxic. Toxicity is low, with a lethal dose of 800 mg/kg in an acute trial.

Testimony Phenotropil

Manifestations of various central nervous system diseases, especially those associated with vascular pathologies and metabolic disorders in the brain, intoxication (including post-traumatic conditions and chronic cerebrovascular insufficiency), are accompanied by impairment of intellectual memory functions and reduced motor activity.

Neurotic conditions manifested by apathy, rapid exhaustion, decreased psychomotor activity, impaired concentration, and impaired memory.
Education is disrupted.
Mild to moderate depression.
Psycho-organic syndromes characterized by intellectual memory disorders and apatico-abulic phenomena, as well as sluggish and apathetic conditions in schizophrenia.

Convulsions.
Obesity (of digestive-constitutional origin).

Prevention of hypoxia, increasing resistance to stress, correction of the functional state of the body in extreme conditions of professional activity, in order to prevent the development of fatigue and increase mental and physical performance, regulation of daily biorhythm, inversion of the "sleep-wake" cycle.

Chronic excessive alcohol use (to decrease asthenic, depressive, and cognitive deficits)

How to use Phenotropil

Reception, dosing range and recommendations
Phenotropil is recommended to be taken by mouth, right after a meal. Dosage and duration of treatment should be determined by a doctor. Doses can be modified depending on the patient’s health. The median single dose is 150 mg (100 mg to 250 mg) and the median daily dose is 250 mg (200 mg to 300 mg). The maximum allowable daily dose is 750 mg. Splitting the daily dose into two doses is recommended. If the daily dosage is less than 100 mg, it should be given once in the morning, and if the dosage is greater than 100 mg, the daily dosage should be divided into two doses. Duration of treatment can vary from two weeks to three months. The average course duration is 30 days. If necessary, treatment can be repeated in a month.

To improve performance, it is recommended to take 100-200 mg once in the morning for two weeks (for athletes - three days).
The recommended treatment duration for patients suffering from nutritional-constitutional obesity is 30 to 60 days at a dose of 100 to 200 mg once a day (morning). Phenotropyl is not recommended after 15:00 hours.